Article
Lack of antagonism between abacavir, lamivudine, and tenofovir against wild-type and drug-resistant HIV-1.
Journal of acquired immune deficiency syndromes (1999) - 15 Aug 2005
Lanier E Randall, Hazen Richard, Ross Lisa, Freeman Andy, Harvey Robert
Abstract excerpt
Potential contributors to the high rate of virologic failure observed for tenofovir, abacavir, and lamivudine include a low genetic barrier to resistance for this regimen and antagonistic drug-drug interactions. To examine the second possibility, we tested combinations of abacavir, tenofovir, and lamivudine against wild-type and drug-resistant HIV-1 in vitro using peripheral blood mononuclear cells and MT-4...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
